The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy. Xu X, Zhao W, Liu C, Gao Y, et al. BMC Cancer 2024;24:13.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu X, Zhao W, Liu C, Gao Y, et al. The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy. BMC Cancer 2024;24:13.
PMID: 38166846